Skip to content

Comparison of physiotherapy: Conventional and using game, in patients with dialysis chronic kidney disease

Comparison between two physical therapy protocols, conventional or with the use of non-immersive virtual reality in patients with chronic dialysis kidney disease: Randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6b6wnsy
Enrollment
Unknown
Registered
2021-02-05
Start date
2020-03-02
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Insufficiency, Chronic

Interventions

Control Group (15 individuals): Conventional Physiotherapy will be performed. The protocol for conventional physiotherapy will be based on the considerations obtained in the evaluations, including cer
L01.224.160.875
H02.010.625

Sponsors

Universidade Federal de Alfenas - Unifal/MG
Lead Sponsor
Universidade Federal de Alfenas - Unifal/MG
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Both sexes, aged 18 years or over, patients from the hemodialysis session of Hospital Santa Casa de Caridade Alfenas Nossa Senhora do Perpétuo Socorro, who undergo hemodialysis session three times a week, using bicipital fistula for access.

Exclusion criteria

Exclusion criteria: Case of hemodynamic instability, pathological fractures, cognitive deficits, including uncoordinated use of devices, uncontrolled Diabetes Mellitus or systemic arterial hypertension.

Design outcomes

Primary

MeasureTime frame
Increase in functional capacity, verified through the ring test (Pegboard and Ring Test), from the significance finding, given by p value less than or equal to 0.05 in Levene's test, both intragroups and intergroups in the pre measurements , 4th session and post intervention.;Increase in handgrip strength, verified by means of dynamometry, based on the finding of significance, given by a p value less than or equal to 0.05 in the Levene test, both within and between groups in the pre-, 4th session and post-intervention measurements .;Increased respiratory muscle strength, verified by means of manovacuometry, based on the finding of significance, given by a p value less than or equal to 0.05 in the Levene test, both within and between groups in the pre-, 4th session and post-intervention measurements.;Increase in global muscle strength, verified through the Medical Research Council (MRC) strength rating, based on the finding of significance, given by a p-value less than or equal to 0.05 in the Levene test, both within and between groups in measurements pre, 4th session and post intervention.;Increased expiratory flow, verified by means of Peak Flow, based on the finding of significance, given by a p-value less than or equal to 0.05 in the Levene test, both intragroups and intergroups in the pre-, 4th session and post-intervention measurements.

Secondary

MeasureTime frame
Improvement in the quality of life levels, verified through the specific questionnaire for patients with chronic kidney disease (KDQOL-SF), based on the finding of significance, given by a p value less than or equal to 0.05 in the Levene test, both intragroups and intergroups in pre and post intervention measurements.;Improvement of plasma levels, verified through laboratory tests, from the finding of significance, given by a p value less than or equal to 0.05 in the Levene test, both within and between groups in the pre and post intervention measurements.

Countries

Brazil

Contacts

Public ContactCarolina Kosour

Universidade Federal de Alfenas - Unifal/MG

carolina.kosour@unifal-mg.edu.br3537011920

Outcome results

None listed

Source: REBEC (via WHO ICTRP)